Álvarez Zurro C. Planas Roca A. Alday Muñoz E. Vega Piris L. Ramasco Rueda F. Méndez Hernández R.

High levels of preoperative and postoperative N terminal B-type natriuretic propeptide influence mortality and cardiovascular complications after noncardiac surgery: a prospective cohort study.

Eur J Anaesthesiol. 33: 444-449Hansen P.W. Gislason G.H. Jørgensen M.E. et al.

Influence of age on perioperative major adverse cardiovascular events and mortality risks in elective non-cardiac surgery.

Eur J Intern Med. 35: 55-59Smilowitz N.R. Gupta N. Ramakrishna H. Guo Y. Berger J.S. Bangalore S.

Perioperative major adverse cardiovascular and cerebrovascular events associated with noncardiac surgery.

JAMA Cardiol. 2: 181-187Duceppe E. Parlow J. MacDonald P. et al.

Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery.

Can J Cardiol. 33: 17-32Fleisher L.A. Fleischmann K.E. Auerbach A.D. et al.

2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.

J Am Coll Cardiol. 64: e77-e137Kristensen S.D. Knuuti J. Saraste A. et al.

2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

Eur J Anaesthesiol. 31: 517-573Paul S.D. Eagle K.A. Kuntz K.M. Young J.R. Hertzer N.R.

Concordance of preoperative clinical risk with angiographic severity of coronary artery disease in patients undergoing vascular surgery.

Circulation. 94: 1561-1566Livhits M. Gibbons M.M. de Virgilio C. et al.

Coronary revascularization after myocardial infarction can reduce risks of noncardiac surgery.

J Am Coll Surg. 212: 1018-1026Livhits M. Ko C.Y. Leonardi M.J. Zingmond D.S. Gibbons M.M. de Virgilio C.

Risk of surgery following recent myocardial infarction.

Ann Surg. 253: 857-864Levine G.N. Bates E.R. Bittl J.A. et al.

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: an update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.

Circulation. 134: e123-e155Yin S.H. Xu P. Wang B. et al.

Duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis.

BMJ. 365: l2222Botto F. Alonso-Coello P. Chan M.T. et al.

Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes.

Anesthesiology. 120: 564-578Thygesen K. Alpert J.S. Jaffe A.S. et al.

Fourth universal definition of myocardial infarction (2018).

J Am Coll Cardiol. 72: 2231-2264De Hert S. Staender S. Fritsch G. et al.

Pre-operative evaluation of adults undergoing elective noncardiac surgery: updated guideline from the European Society of Anaesthesiology.

Eur J Anaesthesiol. 35: 407-465Devereaux P.J. Xavier D. Pogue J. et al.

Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study.

Ann Intern Med. 154: 523-528Foucrier A. Rodseth R. Aissaoui M. et al.

The long-term impact of early cardiovascular therapy intensification for postoperative troponin elevation after major vascular surgery.

Anesth Analg. 119: 1053-1063van Diepen S. Bakal J.A. McAlister F.A. Ezekowitz J.A.

Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients.

Circulation. 124: 289-296Turrentine F.E. Sohn M.W. Jones R.S.

Congestive heart failure and noncardiac operations: risk of serious morbidity, readmission, reoperation, and mortality.

J Am Coll Surg. 222: 1220-1229Lerman B.J. Popat R.A. Assimes T.L. Heidenreich P.A. Wren S.M.

Association of left ventricular ejection fraction and symptoms with mortality after elective noncardiac surgery among patients with heart failure.

JAMA. 321: 572-579Karthikeyan G. Moncur R.A. Levine O. et al.

Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies.

J Am Coll Cardiol. 54: 1599-1606Nicoara A. Swaminathan M.

Diastolic dysfunction, diagnostic and perioperative management in cardiac surgery.

Curr Opin Anaesthesiol. 28: 60-66Roshanov P.S. Rochwerg B. Patel A. et al.

Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patients cohort evaluation prospective cohort.

Anesthesiology. 126: 16-27Lam C.S. Roger V.L. Rodeheffer R.J. Borlaug B.A. Enders F.T. Redfield M.M.

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.

J Am Coll Cardiol. 53: 1119-1126Mohammed S.F. Hussain I. AbouEzzeddine O.F. et al.

Right ventricular function in heart failure with preserved ejection fraction: a community-based study.

Circulation. 130: 2310-2320Mohananey D. Heidari-Bateni G. Villablanca P.A. et al.

Heart failure with preserved ejection fraction: a systematic review and analysis of perioperative outcomes.

J Cardiothorac Vasc Anesth. 32: 2423-2434Kumari K. Ganesh V. Jayant A. Dhawan R. Banayan J.

Perioperative hypertension and diastolic dysfunction.

J Cardiothorac Vasc Anesth. 31: 1487-1496

Management of hypertension in patients undergoing surgery.

Ann Transl Med. 5: 227Venkatesan S. Myles P.R. Manning H.J. et al.

Cohort study of preoperative blood pressure and risk of 30-day mortality after elective non-cardiac surgery.

Br J Anaesth. 119: 65-77Prys-Roberts C. Meloche R. Foëx P.

Studies of anaesthesia in relation to hypertension: I. cardiovascular responses of treated and untreated patients.

Br J Anaesth. 43: 122-137Fleisher L.A. Beckman J.A. Brown K.A. et al.

ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.

Circulation. 116: e418-e499Weksler N. Klein M. Szendro G. et al.

The dilemma of immediate preoperative hypertension: to treat and operate, or to postpone surgery?.

J Clin Anesth. 15: 179-183Sanders R.D. Hughes F. Shaw A. et al.

Perioperative Quality Initiative consensus statement on preoperative blood pressure, risk and outcomes for elective surgery.

Br J Anaesth. 122: 552-562Monk T.G. Bronsert M.R. Henderson W.G. et al.

Association between intraoperative hypotension and hypertension and 30-day postoperative mortality in noncardiac surgery.

Anesthesiology. 123: 307-319Walsh M. Devereaux P.J. Garg A.X. et al.

Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension.

Anesthesiology. 119: 507-515

Preoperative hypertension.

Curr Anesthesiol Rep. 8: 25-31Meng L. Yu W. Wang T. Zhang L. Heerdt P.M. Gelb A.W.

Blood pressure targets in perioperative care.

Hypertension. 72: 806-817

Hypertension in the immediate postoperative period.

Br J Anaesth. 47: 70-74

Risks of general anesthesia and elective operation in the hypertensive patient.

Anesthesiology. 50: 285-292

Withdrawal syndromes and the cessation of antihypertensive therapy.

Arch Intern Med. 141: 1125-1127Johnson W. Nguyen M.L. Patel R.

Hypertension crisis in the emergency department.

Cardiol Clin. 30: 533-543

Acute severe hypertension.

N Engl J Med. 381: 1843-1852Whelton P.K. Carey R.M. Aronow W.S. et al.

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Hypertension. 71: 1268-1324Forrest J.B. Cahalan M.K. Rehder K. et al.

Multicenter study of general anesthesia: II. results.

Anesthesiology. 72: 262-268Forrest J.B. Rehder K. Cahalan M.K. Goldsmith C.H.

Multicenter study of general anesthesia: III. predictors of severe perioperative adverse outcomes.

Anesthesiology. 76: 3-15Polanczyk C.A. Goldman L. Marcantonio E.R. Orav E.J. Lee T.H.

Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay.

Ann Intern Med. 129: 279-285Poldermans D. Bax J.J. Boersma E. et al.

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA).

Eur J Anaesthesiol. 27: 92-137Stewart A.M. Greaves K. Bromilow J.

Supraventricular tachyarrhythmias and their management in the perioperative period.

Contin Educ Anaesth Crit Care Pain. 15: 90-97Vaporciyan A.A. Correa A.M. Rice D.C. et al.

Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients.

J Thorac Cardiovasc Surg. 127: 779-786Vallurupalli S. Shanbhag A. Mehta J.L.

Controversies in postoperative atrial fibrillation after noncardiothoracic surgery: clinical and research implications.

Clin Cardiol. 40: 329-332Groenveld H.F. Tijssen J.G. Crijns H.J. et al.

Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).

J Am Coll Cardiol. 61: 741-748Bhave P.D. Goldman L.E. Vittinghoff E. Maselli J. Auerbach A.

Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery.

Am Heart J. 164: 918-924Butt J.H. Olesen J.B. Havers-Borgersen E. et al.

Risk of thromboembolism associated with atrial fibrillation following noncardiac surgery.

J Am Coll Cardiol. 72: 2027-2036Danelich I.M. Lose J.M. Wright S.S. et al.

Practical management of postoperative atrial fibrillation after noncardiac surgery.

J Am Coll Surg. 219: 831-841January C.T. Wann L.S. Alpert J.S. et al.

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

J Am Coll Cardiol. 64: e1-e76Van Gelder I.C. Groenveld H.F. Crijns H.J. et al.

Lenient versus strict rate control in patients with atrial fibrillation.

N Engl J Med. 362: 1363-1373Mahla E. Rotman B. Rehak P. et al.

Perioperative ventricular dysrhythmias in patients with structural heart disease undergoing noncardiac surgery.

Anesth Analg. 86: 16-21O'Kelly B. Browner W.S. Massie B. Tubau J. Ngo L. Mangano D.T.

Ventricular arrhythmias in patients undergoing noncardiac surgery. the Study of Perioperative Ischemia Research Group.

JAMA. 268: 217-221Amar D. Zhang H. Roistacher N.

The incidence and outcome of ventricular arrhythmias after noncardiac thoracic surgery.

Anesth Analg. 95: 537-543Al-Khatib S.M. Stevenson W.G. Ackerman M.J. et al.

2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary.

Circulation. 138: e210-e271Tracy C.M. Epstein A.E. Darbar D. et al.

2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected].

Circulation. 126: 1784-1800Gregoratos G. Abrams J. Epstein A.E. et al.

ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).

Circulation. 106: 2145-2161Kusumoto F.M. Schoenfeld M.H. Barrett C. et al.

2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay.

Circulation. 140: e382-e482Pastore J.O. Yurchak P.M. Janis K.M. Murphy J.D. Zir L.M.

The risk of advanced heart block in surgical patients with right bundle branch block and left axis deviation.

Circulation. 57: 677-680

Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach.

Clin Pharmacokinet. 38: 377-392Burger W. Chemnitius J.M. Kneissl G.D. Rucker G.

Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: review and meta-analysis.

J Intern Med. 257: 399-414

Antiplatelet drug discontinuation is a risk factor for ischemic stroke.

Neurology. 62: 1187-1189Devereaux P.J. Mrkobrada M. Sessler D.I. et al.

Aspirin in patients undergoing noncardiac surgery.

N Engl J Med. 370: 1494-1503Graham M.M. Sessler D.I. Parlow J.L. et al.

Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery.

Ann Intern Med. 168: 237-244Zimmermann A. Knappich C. Tsantilas P. et al.

Different perioperative antiplatelet therapies for patients treated with carotid endarterectomy in routine practice.

J Vasc Surg. 68: 1753-1763Belch J.J. Dormandy J. et al.CASPAR Writing Committee

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.

J Vasc Surg. 52 (): 825-833Hess C.N. Norgren L. Ansel G.M. et al.

A structured review of antithrombotic therapy in peripheral artery disease with a focus on revascularization: a TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) initiative.

Circulation. 135: 2534-2555Stone D.H. Goodney P.P. Schanzer A. et al.

Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery.

J Vasc Surg. 54: 779-784Hui A.J. Wong R.M. Ching J.Y. Hung L.C. Chung S.C. Sung J.J.

Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases.

Gastrointest Endosc. 59: 44-48Katz J. Feldman M.A. Bass E.B. et al.

Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery.

Ophthalmology. 110: 1784-1788Ockerman A. Bornstein M.M. Leung Y.Y. Li S.K.Y. Politis C. Jacobs R.

Incidence of bleeding after minor oral surgery in patients on dual antiplatelet therapy: a systematic review and meta-analysis.

Int J Oral Maxillofac Surg. 49: 90-98Yousfi M. Gostout C.J. Baron T.H. et al.

Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin.

Am J Gastroenterol. 99: 1785-1789Collet J.P. Montalescot G. Blanchet B. et al.

Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes.

Circulation. 110: 2361-2367Cutlip D.E. Baim D.S. Ho K.K. et al.

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.

Circulation. 103: 1967-1971Moreno R. Fernandez C. Hernandez R. et al.

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies.

J Am Coll Cardiol. 45: 954-959Chassot P.G. Delabays A. Spahn D.R.

Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction.

Br J Anaesth. 99: 316-328Humenberger M. Stockinger M. Kettner S. Siller-Matula J. Hajdu S.

Impact of antiplatelet therapies on patients outcome in osteosynthetic surgery of proximal femoral fractures.

J Clin Med. 8: 2176Soo C.G. Della Torre P.K. Yolland T.J. Shatwell M.A.

Clopidogrel and hip fractures, is it safe? A systematic review and meta-analysis.

BMC Musculoskelet Disord. 17: 136Kwon S. Thompson R. Florence M. et al.

β-blocker continuation after noncardiac surgery: a report from the surgical care and outcomes assessment program.

Arch Surg. 147: 467-473Wallace A.W. Au S. Cason B.A.

Association of the pattern of use of perioperative β-blockade and postoperative mortality.

Anesthesiology. 113: 794-805Devereaux P.J. Yang H. et al.POISE Study Group

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial.

Lancet. 371: 1839-1847Chopra V. Wesorick D.H. Sussman J.B. et al.

Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: a systematic review and meta-analysis.

Arch Surg. 147: 181-189Winchester D.E. Wen X. Xie L. Bavry A.A.

Evidence of pre-procedural statin therapy a meta-analysis of randomized trials.

J Am Coll Cardiol. 56: 1099-1109Hollmann C. Fernandes N.L. Biccard B.M.

A systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery.

Anesth Analg. 127: 678-687Kheterpal S. Khodaparast O. Shanks A. O'Reilly M. Tremper K.K.

Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.

J Cardiothorac Vasc Anesth. 22: 180-186Turan A. You J. Shiba A. Kurz A. Saager L. Sessler D.I.

Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery.

Anesth Analg. 114: 552-560Legrand M. Futier E. Leone M. et al.

Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial).

Trials. 20: 160Devereaux P.J. Sessler D.I. Leslie K. et al.

Clonidine in patients undergoing noncardiac surgery.

N Engl J Med. 370: 1504-1513

Blood pressure lowering effect of calcium channel blockers on perioperative hypertension: a systematic review and meta-analysis.

Medicine (Baltimore). 97: e13152Hu Y. Yang X. Zhang L. et al.

Perioperative diltiazem or nitroglycerin in on-pump coronary artery bypass: a systematic review and network meta-analysis.

PLoS One. 13: e0331520Hirsch I.A. Tomlinson D.L. Slogoff S. Keats A.S.

The overstated risk of preoperative hypokalemia.

Anesth Analg. 67: 131-136Khan N.A. Campbell N.R. Frost S.D. et al.

Risk of intraoperative hypotension with loop diuretics: a randomized controlled trial.

Am J Med. 123: 1059.e1-1059.e8